2025
What Lessons can Be Learned From the Management of the COVID-19 Pandemic?
Quinn G, Connolly R, ÓhAiseadha C, Hynds P, Bagus P, Brown R, Cáceres C, Craig C, Connolly M, Domingo J, Fenton N, Frijters P, Hatfill S, Heymans R, Joffe A, Jones R, Lauc G, Lawrie T, Malone R, Mordue A, Mushet G, O’Connor A, Orient J, Peña-Ramos J, Risch H, Rose J, Sánchez-Bayón A, Savaris R, Schippers M, Simandan D, Sikora K, Soon W, Shir-Raz Y, Spandidos D, Spira B, Tsatsakis A, Walach H. What Lessons can Be Learned From the Management of the COVID-19 Pandemic? International Journal Of Public Health 2025, 70: 1607727. PMID: 40529997, PMCID: PMC12171511, DOI: 10.3389/ijph.2025.1607727.Peer-Reviewed Original Research
2020
Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis
Risch HA. Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis. American Journal Of Epidemiology 2020, 189: 1218-1226. PMID: 32458969, PMCID: PMC7546206, DOI: 10.1093/aje/kwaa093.Peer-Reviewed Original ResearchConceptsOutpatient treatmentHigh-risk COVID-19 patientsSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2High-risk patientsUse of hydroxychloroquineMultiple comorbid conditionsCOVID-19 patientsEfficacy of hydroxychloroquineEarly outpatient treatmentStandard of careSyndrome coronavirus 2Mild effectivenessOutpatient diseasesOutpatient illnessOutpatient trialSuch patientsSymptomatic diseaseComorbid conditionsCoronavirus 2Hospitalized inpatientsClinical trialsCandidate medicationsHydroxychloroquine
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply